ApoE genotype and abnormal auditory cortical potentials in healthy older females

Neurobiology of Aging

Volumn 31, Issue 10, 2010, Pages 1799-1804

  Irimajiri, Rie ^a   Golob, Edward J ^b   Starr, Arnold ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

Aging; Apolipoprotein E; Auditory event related potentials; P300; P50

Indexed keywords

APOLIPOPROTEIN E4;

AGED; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; EVOKED CORTICAL RESPONSE; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; LATENT PERIOD; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; AUDITORY CORTEX; AUDITORY PERCEPTION; AUDITORY PERCEPTUAL DISORDERS; EVOKED POTENTIALS; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 77955847278     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.09.005     Document Type: Article

References (41)

1. Alexander G.E., Chen K., Pietrini P., Rapoport S.I., Reiman E.M. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am. J. Psychiatry 2002, 159:738-745.
2. Babiloni C., Benussi L., Binetti G., Cassetta E., Dal Forno G., Del Percio C., Ferreri F., Ferri R., Frisoni G., Ghidoni R., Miniussi C., Rodriguez G., Romani G.L., Squitti R., Ventriglia M.C., Rossini P.M. Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric electroencephalogram study. Ann. Neurol. 2006, 59:323-334.
3. Bäckman L., Andersson J.L., Nyberg L., Winblad B., Nordberg A., Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 1999, 52:1861-1870.
4. Black S.C., Hewett S., Kotubi Y., Brunt R.V., Reckless J.P. Isoform patterns of apolipoprotein E in diabetes mellitus. Diabet. Med. 1990, 7:532-539.
5. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 2000, 343:450-456.
6. Braak H., Braak E., Bohl J., Bratzke H. Evolution of Alzheimer's disease related cortical lesions. J. Neural. Transm. Suppl. 1998, 54:97-106.
7. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
8. Donchin E., Coles M.G. Is the P300 component a manifestation of context updating?. Behav. Brain Sci. 1988, 11:357-374.
9. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
10. Fleisher A., Grundman M., Jack C.R.J., Petersen R.C., Taylor C., Kim H.T., Schiller D.H., Bagwell V., Sencakova D., Weiner M.F., DeCarli C., DeKosky S.T., van Dyck C.H., Thal L.J. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch. Neurol. 2005, 62:953-957. Study AsDC.
11. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
12. Frackowiak R.S., Pozzilli C., Legg N.J., Du Boulay G.H., Marshall J., Lenzi G.L., Jones T. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981, 104:753-778.
13. Golob E.J., Irimajiri R., Starr A. Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia. Brain 2007, 130:740-752.
14. Golob E.J., Johnson J.K., Starr A. Auditory event-related potentials during target detection are abnormal in mild cognitive impairment. Clin. Neurophysiol. 2002, 113:151-161.
15. Goodin D.S., Squires K.C., Henderson B.H., Starr A. Age-related variations in evoked potentials to auditory stimuli in normal human subjects. Electroencephalogr. Clin. Neurophysiol. 1978, 44:447-458.
16. Green J., Levey A.I. Event-related potential changes in groups at increased risk for Alzheimer disease. Arch. Neurol. 1999, 56:1398-1403.
17. Halgren E., Marinkovic K., Chauvel P. Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr. Clin. Neurophysiol. 1998, 106:156-164.
18. Irimajiri R., Golob E.J., Starr A. Auditory brain-stem, middle- and long-latency evoked potentials in mild cognitive impairment. Clin. Neurophysiol. 2005, 116:1918-1929.
19. Jasper H.H. The ten-twenty electrode system of the international federation. Electroencephalogr. Clin. Neurophysiol. 1958, 10:371-375.
20. Kaplan, E., Snodgrass, H., Weintraub, S., 1983. Boston Naming Test, vol. Lea and Febiger, Philadelphia, PA.
21. Kisley M.A., Davalos D.B., Engleman L.L., Guinther P.M., Davis H.P. Age-related change in neural processing of time-dependent stimulus features. Brain Res. Cogn. Brain Res. 2005, 25:913-925.
22. Lind J., Ingvar M., Persson J., Sleegers K., Van Broeckhoven C., Adolfsson R., Nilsson L.G., Nyberg L. Parietal cortex activation predicts memory decline in apolipoprotein E-epsilon4 carriers. NeuroReport 2006, 17:1683-1686.
23. Morris J.C. Dementia update 2003. Alzheimer. Dis. Assoc. Disord. 2003, 17:245-258.
24. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989, 39:1159-1165.
25. Mortensen E.L., Høgh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 2001, 57:89-95.
26. Näätänen R., Gaillard A.W., Mäntysalo S. Early selective-attention effect on evoked potential reinterpreted. Acta Psychol. (Amst) 1978, 42:313-329.
27. Näätänen R., Tervaniemi M., Sussman E., Paavilainen P., Winkler I. " Primitive intelligence" in the auditory cortex. Trends Neurosci. 2001, 24:283-288.
28. Packard C.J., Westendorp R.G., Stott D.J., Caslake M.J., Murray H.M., Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Cobbe S.M., Ford I., Gaw A., Hyland M., Jukema J.W., Kamper A.M., Macfarlane P.W., Jolles J., Perry I.J., Sweeney B.J., Twomey C. Association between apolipoprotein E4 and cognitive decline in elderly adults. J. Am. Geriatr. Soc. 2007, 55:1777-1785. Group PSoPitEaR.
29. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993, 342:697-699.
30. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and " preclinical" Alzheimer's disease. Ann. Neurol. 1999, 45:358-368.
31. Reiman E.M., Caselli R.J., Chen K., Alexander G.E., Bandy D., Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:3334-3339.
32. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 1996, 334:752-758.
33. Reinvang I., Espeseth T., Gjerstad L. Cognitive ERPs are related to ApoE allelic variation in mildly cognitively impaired patients. Neurosci. Lett. 2005, 382:346-351.
34. Reitan R.M. Validity of the trail making test as an indicator of organic brain damage. Percept. Mot. Skills 1958, 8:271-276.
35. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth P., Rasgon N.L., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6037-6042.
36. Smith C.D., Andersen A.H., Kryscio R.J., Schmitt F.A., Kindy M.S., Blonder L.X., Avison M.J. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology 1999, 53:1391-1396.
37. Spreen, O., Benton, A.L., 1977. Neurosensory center comprehensive examination for aphasia, vol. Neuropsychology Laboratory, University of Victoria, Victoria, B.C.
38. Sutton S., Braren M., Zubin J., John E.R. Evoked-potential correlates of stimulus uncertainty. Science 1965, 150:1187-1188.
39. van der Vlies A.E., Pijnenburg Y.A., Koene T., Klein M., Kok A., Scheltens P., van der Flier W.M. Cognitive impairment in Alzheimer's disease is modified by APOE genotype. Dement. Geriatr. Cogn. Disord. 2007, 24:98-103.
40. Wechsler, D., 1981. Wechsler Adult Intelligence Scale - Revised, vol. Harcourt Brace Jovanovich, New York, NY.
41. Wechsler, D., 1997. Wechsler memory scale, vol. Psychological Corporation, San Antonio.